Quots for 8/antibiotic – Spiramycin - Dihydroartemisinin Tabs – KeMing Medicines Detail:
FOB Price | Inquiry |
Min.Order Quantity | 1,000,000 tablets |
Supply Ability | 120,000,000 tablets/Month |
Port | Shanghai |
Payment Terms | T/T in advance |
Product Detail | |
Product name | Dihydroartemisinin Tabs |
Specification | 60mg |
Description | A white film-coated tablet |
Standard | CP |
Package | 8’s/blister/box |
Transportation | Ocean,Land,Air |
Certificate | GMP |
Price | Inquiry |
Quality guaranteeperiod | for 36 months |
Product Description | [Pharmacology] Powerful plasmodicide of malaria parasite agamete which quickly controls symptoms. Highly effective against all forms of malaria including multi_drug resistant malaria. It has high safety and low toxicity.Reproduction toxicology,increase fetal absorption during pregnancy in mice.No mutation effect observed. 60mg for the following 4 or 6 days.See tablet below for children. |
Product detail pictures:
Related Product Guide:
Disease, Doctors, Drugs and Vitamins!
Prescription Drugs Can Lead to Vitamin and Mineral Deficiencies
We stay with the basic principle of "quality initially, services first, steady improvement and innovation to fulfill the customers" for your management and "zero defect, zero complaints" as the quality objective. To perfect our company, we give the goods while using the good high-quality at the reasonable selling price for Quots for 8/antibiotic – Spiramycin - Dihydroartemisinin Tabs – KeMing Medicines, The product will supply to all over the world, such as: Egypt, Curacao, Italy, With all these supports, we can serve every customer with quality product and timely shipping with highly responsibility. Being a young growing company, we might not the best, but we're trying our best to be your good partner.
By Rigoberto Boler from Luxembourg - 2017.12.31 14:53
The company account manager has a wealth of industry knowledge and experience, he could provide appropriate program according our needs and speak English fluently.
By Novia from Haiti - 2017.07.28 15:46